
James Schultz
Examiner (ID: 14322, Phone: (571)272-0763 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1631, 1635 |
| Total Applications | 977 |
| Issued Applications | 385 |
| Pending Applications | 182 |
| Abandoned Applications | 415 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5458250
[patent_doc_number] => 20090258402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'L-Glutamic Acid Producing Bacterium and a Method for Production of L-Glutamic Acid'
[patent_app_type] => utility
[patent_app_number] => 12/034101
[patent_app_country] => US
[patent_app_date] => 2008-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8310
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258402.pdf
[firstpage_image] =>[orig_patent_app_number] => 12034101
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/034101 | L-glutamic acid producing bacterium and a method for production of L-glutamic acid | Feb 19, 2008 | Issued |
Array
(
[id] => 6529893
[patent_doc_number] => 20100015218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/526869
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 109173
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015218.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526869 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES | Feb 14, 2008 | Abandoned |
Array
(
[id] => 4820296
[patent_doc_number] => 20080226595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/030161
[patent_app_country] => US
[patent_app_date] => 2008-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 48769
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030161
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030161 | Treatment of inflammatory diseases using placental stem cells | Feb 11, 2008 | Issued |
Array
(
[id] => 6413627
[patent_doc_number] => 20100166842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'AMPHIPHILIC SUBSTANCES AND FUNCTIONALIZED LIPID VESICLES INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/523443
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9191
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523443 | Amphiphilic substances and functionalized lipid vesicles including the same | Jan 15, 2008 | Issued |
Array
(
[id] => 6320311
[patent_doc_number] => 20100196338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/522714
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11549
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196338.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522714 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE | Jan 9, 2008 | Abandoned |
Array
(
[id] => 7800851
[patent_doc_number] => 08129121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/448840
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 21
[patent_no_of_words] => 10884
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448840 | Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof | Jan 7, 2008 | Issued |
Array
(
[id] => 6159722
[patent_doc_number] => 20110159020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/518061
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 6668
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518061 | Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof | Dec 6, 2007 | Abandoned |
Array
(
[id] => 4826716
[patent_doc_number] => 20080229437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Intergeneric bivalve shellfish hybrid and method for producing'
[patent_app_type] => utility
[patent_app_number] => 11/986317
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5767
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20080229437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986317 | Intergeneric bivalve shellfish hybrid and method for producing | Nov 19, 2007 | Abandoned |
Array
(
[id] => 4903517
[patent_doc_number] => 20080112930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Methods of treating restenosis'
[patent_app_type] => utility
[patent_app_number] => 11/982883
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13726
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20080112930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11982883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/982883 | Methods of treating restenosis | Nov 5, 2007 | Abandoned |
Array
(
[id] => 5422881
[patent_doc_number] => 20090149336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Indexed library of cells containing genomic modifications and methods of making and utilizing the same'
[patent_app_type] => utility
[patent_app_number] => 11/978961
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12815
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978961 | Indexed library of cells containing genomic modifications and methods of making and utilizing the same | Oct 28, 2007 | Abandoned |
Array
(
[id] => 9427109
[patent_doc_number] => 08703180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-04-22
[patent_title] => 'Multiple growth factor compositions, methods of fabrication, and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/877635
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11877635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877635 | Multiple growth factor compositions, methods of fabrication, and methods of treatment | Oct 22, 2007 | Issued |
Array
(
[id] => 5428169
[patent_doc_number] => 20090087479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Orally bioavailable lipid-based constructs'
[patent_app_type] => utility
[patent_app_number] => 11/904937
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11857
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904937
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904937 | Orally bioavailable lipid-based constructs | Sep 27, 2007 | Issued |
Array
(
[id] => 6483903
[patent_doc_number] => 20100008977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/439636
[patent_app_country] => US
[patent_app_date] => 2007-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9305
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439636
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439636 | LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES | Sep 2, 2007 | Abandoned |
Array
(
[id] => 5446910
[patent_doc_number] => 20090048136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'KAPPA-CARRAGEENASE AND KAPPA-CARRAGEENASE-CONTAINING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/838884
[patent_app_country] => US
[patent_app_date] => 2007-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14514
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048136.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838884 | KAPPA-CARRAGEENASE AND KAPPA-CARRAGEENASE-CONTAINING COMPOSITIONS | Aug 14, 2007 | Abandoned |
Array
(
[id] => 5507964
[patent_doc_number] => 20090081171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Cell system for alleviating syndromes of Parkinson\'s disease in a mammal'
[patent_app_type] => utility
[patent_app_number] => 11/891935
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13153
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11891935
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891935 | Cell system for alleviating syndromes of Parkinson's disease in a mammal | Aug 12, 2007 | Abandoned |
Array
(
[id] => 11611535
[patent_doc_number] => 09649379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/452825
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 7177
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452825
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452825 | Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma | Jul 24, 2007 | Issued |
Array
(
[id] => 102660
[patent_doc_number] => 07723316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases'
[patent_app_type] => utility
[patent_app_number] => 11/824426
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20293
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11824426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/824426 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Jun 28, 2007 | Issued |
Array
(
[id] => 5570400
[patent_doc_number] => 20090253778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'DNA composition against tumor stromal antigen FAP and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/820823
[patent_app_country] => US
[patent_app_date] => 2007-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12432
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253778.pdf
[firstpage_image] =>[orig_patent_app_number] => 11820823
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/820823 | DNA composition against tumor stromal antigen FAP and methods of use thereof | Jun 20, 2007 | Abandoned |
Array
(
[id] => 5323017
[patent_doc_number] => 20090061007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Pharmaceutical preparation'
[patent_app_type] => utility
[patent_app_number] => 11/812459
[patent_app_country] => US
[patent_app_date] => 2007-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11896
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20090061007.pdf
[firstpage_image] =>[orig_patent_app_number] => 11812459
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/812459 | Pharmaceutical preparation | Jun 18, 2007 | Issued |
Array
(
[id] => 6453578
[patent_doc_number] => 20100154072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'siRNA Kinase and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/302583
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13497
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20100154072.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302583 | siRNA Kinase and Methods of Use | May 28, 2007 | Abandoned |